减重创新研发论坛

返回主日程
14:00 - 15:30
  • 主持人 Moderator
  • 赵永新, 杭州多禧生物科技股份有限公司创始人、董事长、CEO
  • ZHAO Yongxin, Founder, Chairman of the Board and CEO of Hangzhou DAC Biotechnology Co., Ltd.
14:00 - 14:30
  • 主题报告1
  • Keynote Speech 1
  • 以临床需求为导向的肥胖药物开发
  • Clinical Needs-Driven Drug Development for Obesity
  • 王瀚之, 苏利文·克伦威尔律师事务所律师
  • WANG Hanzhi, Associate, Sullivan & Cromwell LLP
14:30 - 15:00
  • 主题报告2
  • Keynote Speech 2
  • ActRII药物在增肌减脂领域的研发进展
  • Targeting ActRII for Muscle Preservation and Fat Reduction in Obesity
  • 王亦文, 苏利文·克伦威尔律师事务所律师
  • WANG Yiwen, Associate, Sullivan & Cromwell LLP
15:00 - 15:30
  • 主题报告3
  • Keynote Speech 3
  • 超长效减重药物开发策略
  • Development of Ultra-Long-Acting Anti-Obesity Medications
  • 张炜, 达石药业（广东）有限公司总裁兼首席运营官
  • Larry ZHANG, President & COO, Dartsbio Pharmaceuticals, Ltd.
15:30 - 16:30
  • 主持人 Moderator
  • 李宗海, 科济药业联合创始人、董事会主席、首席执行官、首席科学官
  • LI Zonghai, Co-founder, Chairman of the Board, CEO, CSO ，CARsgen Therapeutics
15:30 - 16:00
  • 主题报告4
  • Keynote Speech 4
  • 减重药物开发布局与趋势
  • Overview of Weight Loss Drug Development Landscape
  • 刘立鹤, CIC灼识合伙人
  • Luke LIU, Partner, CIC
16:00 - 16:30
  • 主题报告5
  • Keynote Speech 5
  • 减重药物创新研发的思考
  • Reflections on the Innovative Research and Development of Anti-Obesity Medicines
  • 余润泽, 聚明创投投资总监
  • Raphael YU, Director, MING Bioventures
16:30 - 17:10
  • 主题讨论
  • Panel
  • 突围减重赛道：差异化竞争、支付瓶颈与临床价值回归
  • How to Navigate the Anti-Obesity Drug Development Space
    • 主持人 Moderator
  • 王瀚之, 苏利文·克伦威尔律师事务所律师
  • WANG Hanzhi, Associate, Sullivan & Cromwell LLP
    • 讨论嘉宾：
    Panelist:
  • 赵永新, 杭州多禧生物科技股份有限公司创始人、董事长、CEO
  • ZHAO Yongxin, Founder, Chairman of the Board and CEO of Hangzhou DAC Biotechnology Co., Ltd.
  • 薛轶, 毅达资本高级合伙人
  • XUE Yi, Senior Partner, Addor Capital
  • 刘靓, 深圳无尽方舟科技有限公司早期孵化人兼总裁，清华深圳研究院长寿虚拟细胞研发中心执行主任
  • LIU Liang, Early Incubator and President of Shenzhen EonArk.AI Technology Co., Ltd. and Executive Director, Longevity Virtual Cell R&D Center, Research Institute of Tsinghua University in Shenzhen
  • 王印祥, 中国药促会研发专委会资深主委，加科思药业董事长兼联席CEO
  • WANG Yinxiang, Chairman and Co-CEO, Jacobio Pharma
  • 许麟, 中信银行上海分行科技金融中心副总经理
  • XU Lin, Dupty General Manager, CITIC Bank Shanghai Branch Sci-tech Innovation Finance Center
  • 秦叔逵, 中国药促会抗肿瘤专委会主委，浙江钱塘高等研究院钱塘学者兼临床肿瘤研究所所长
  • QIN Shukui, Chairman of Anti-Tumor Committee of PhIRDA, Qiantang Scholar at Zhejiang Qiantang Advanced Research Institute, and Director of the Clinical Oncology Research Institute